Imiquimod in human CD8+ T cells

ABSTRACT: Blood CD8 T cells from six healthy blood donors were treated with the TLR7 agonist imiquimod + IL-2 in T cell enriched medium overnight in vitro (the controls were incubated with T cell enriched medium + IL-2 only). After approx. 21 h the in solution digest protocol was started.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): T Cell, Blood

SUBMITTER: Proteomics Facility  

LAB HEAD: Mario Fabri

PROVIDER: PXD038621 | Pride | 2024-04-29

REPOSITORIES: Pride